Global Non-invasive Preimplantation Genetic Testing Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Non-invasive Preimplantation Genetic Testing Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Non-invasive Preimplantation Genetic Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).

The Global Info Research report includes an overview of the development of the Non-invasive Preimplantation Genetic Testing industry chain, the market status of Hospitals (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), Diagnostic Laboratories (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Non-invasive Preimplantation Genetic Testing.

Regionally, the report analyzes the Non-invasive Preimplantation Genetic Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Non-invasive Preimplantation Genetic Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Non-invasive Preimplantation Genetic Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Non-invasive Preimplantation Genetic Testing industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Non-invasive Preimplantation Genetic Testing market.

Regional Analysis: The report involves examining the Non-invasive Preimplantation Genetic Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Non-invasive Preimplantation Genetic Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Non-invasive Preimplantation Genetic Testing:

Company Analysis: Report covers individual Non-invasive Preimplantation Genetic Testing manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Non-invasive Preimplantation Genetic Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostic Laboratories).

Technology Analysis: Report covers specific technologies relevant to Non-invasive Preimplantation Genetic Testing. It assesses the current state, advancements, and potential future developments in Non-invasive Preimplantation Genetic Testing areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Non-invasive Preimplantation Genetic Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Non-invasive Preimplantation Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Market segment by Application
Hospitals
Diagnostic Laboratories
Other

Major players covered
Illumina
Thermo Fisher Scientific
Agilent
Revvity
The Cooper Companies
Abbott
TAKARA
QIAGEN
Vitrolife
Oxford Nanopore Technologies
Yikon Genomics
Shiva Scientific
Medicover Genetics
MedGenome
Fulgent
INVICTA GENETICS
Genea Fertility
Bioarray
GeneMind Biosciences
Unimed Biotech

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Non-invasive Preimplantation Genetic Testing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Non-invasive Preimplantation Genetic Testing, with price, sales, revenue and global market share of Non-invasive Preimplantation Genetic Testing from 2018 to 2023.

Chapter 3, the Non-invasive Preimplantation Genetic Testing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Non-invasive Preimplantation Genetic Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-invasive Preimplantation Genetic Testing market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Non-invasive Preimplantation Genetic Testing.

Chapter 14 and 15, to describe Non-invasive Preimplantation Genetic Testing sales channel, distributors, customers, research findings and conclusion.